Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

Rhea-AI Summary

Haemonetics (NYSE: HAE) announced that financial results for its first quarter of fiscal 2027, for the period ended June 27, 2026, are now available on its Investor Relations website. The company will host an investor conference call and live webcast at 8:00 a.m. ET on August 6, 2026, with a replay available from 11:00 a.m. ET the same day for one year. Haemonetics has also posted its First Quarter Fiscal 2027 earnings release and a supplemental earnings presentation online, which will be referenced during the call.

Market Context

Current risk context classified HAE’s short positioning as low. Against that backdrop, the earnings ...

Analysis

Current risk context classified HAE’s short positioning as low. Against that backdrop, the earnings announcement adds a scheduled results discussion, while the tag-matched record supplies historical variability and leaves reported results as the key item to assess.

Key Figures

Fiscal reporting period: First quarter fiscal 2027 Quarter end: June 27, 2026 Conference call time: 8:00 a.m. ET +2 more

5 metrics

Fiscal reporting period First quarter fiscal 2027 Results period announced

Quarter end June 27, 2026 First quarter fiscal 2027

Conference call time 8:00 a.m. ET August 6, 2026

Replay start time 11:00 a.m. ET August 6, 2026

Replay availability One year Via the webcast link

Previous Earnings Reports

5 past events · Latest: May 07 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 07	4Q26 earnings report	Neutral	+3.2%	Posted fourth-quarter fiscal 2026 results and scheduled an investor conference call
Feb 05	3Q26 earnings report	Neutral	-1.4%	Posted third-quarter fiscal 2026 results and scheduled a conference call and webcast
Nov 06	2Q26 earnings report	Neutral	+32.3%	Posted second-quarter fiscal 2026 results and announced webcast replay availability
Aug 07	1Q26 earnings report	Neutral	-26.6%	Posted first-quarter fiscal 2026 results and scheduled an investor conference call
May 08	4Q25 earnings report	Neutral	+5.8%	Posted fourth-quarter and fiscal-year 2025 results with fiscal 2026 guidance materials

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-matched earnings notices produced mixed 24-hour reactions, with both positive and negative outcomes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Financial release and supplemental presentation accessible online

BOSTON, Aug. 6, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2027, which ended June 27, 2026, are available on the Company's Investor Relations website at www.haemonetics.com.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 6, 2026.

Conference Call and Webcast Information:

• Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
• Live webcast: Access here or through the Investor Relations section of the Haemonetics website.

A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on August 6, 2026 and will remain accessible for one year via the webcast link above.

Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:

• First Quarter Fiscal 2027 Earnings Release
• First Quarter Fiscal 2027 Supplemental Earnings Presentation

ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury       
(781) 356-9763                                                                           
olga.guyette@haemonetics.com                                              

David Trenk, Sr. Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com

Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-first-quarter-fiscal-2027-financial-results-available-on-investor-relations-website-302844070.html

SOURCE Haemonetics Corporation

FAQ

Where can investors find Haemonetics (NYSE: HAE) Q1 fiscal 2027 financial results?

Haemonetics’ Q1 fiscal 2027 results are available on the company’s Investor Relations website. According to Haemonetics, investors can access the full earnings release and related materials at www.haemonetics.com in the Investor Relations section.

When is Haemonetics’ Q1 FY 2027 earnings conference call scheduled?

Haemonetics’ Q1 fiscal 2027 earnings conference call is scheduled for 8:00 a.m. ET on August 6, 2026. According to Haemonetics, investors and analysts can join via phone or live webcast after registering online.

How can I register for the Haemonetics (HAE) Q1 2027 earnings conference call?

Investors can register using the company’s provided online registration link. According to Haemonetics, registrants receive dial-in details and a personalized PIN, and are encouraged to join about 10 minutes before the start time.

Will a replay of Haemonetics’ August 6, 2026 earnings call be available?

Yes, a replay of Haemonetics’ earnings call will be available from 11:00 a.m. ET on August 6, 2026 for one year. According to Haemonetics, it can be accessed via the same webcast link through the Investor Relations website.

What earnings materials did Haemonetics post for Q1 fiscal 2027?

Haemonetics posted its First Quarter Fiscal 2027 Earnings Release and a Supplemental Earnings Presentation. According to Haemonetics, these materials are available on the Investor Relations website and will be referenced during the conference call and webcast.